{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T21:09:59Z","timestamp":1776978599236,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ajo.2024.08.034","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T07:03:30Z","timestamp":1725087810000},"page":"315-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Silk-Derived Protein-4 Versus Vehicle Control in Treating Patients With Moderate to Severe Dry Eye Disease: A Randomized Clinical Trial"],"prefix":"10.1016","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3223-7777","authenticated-orcid":false,"given":"Brian D.","family":"Lawrence","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Karpecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2944-1004","authenticated-orcid":false,"given":"David W.","family":"Infanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2024.08.034_bib0001","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajo.2019.01.026","article-title":"Estimated prevalence and incidence of dry eye disease based on coding analysis of a large, all-age United States Health Care System","volume":"202","author":"Dana","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2024.08.034_bib0002","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jtos.2012.04.001","article-title":"Nuclear Factor-\u03baB: central regulator in ocular surface inflammation and diseases","volume":"10","author":"Lan","year":"2012","journal-title":"The Ocular Surface"},{"key":"10.1016\/j.ajo.2024.08.034_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108115","article-title":"Biological functions of tear film","volume":"197","author":"Pflugfelder","year":"2020","journal-title":"Exp Eye Res"},{"issue":"3","key":"10.1016\/j.ajo.2024.08.034_bib0004","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.exer.2009.12.009","article-title":"Effect of pro-inflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells","volume":"90","author":"Albertsmeyer","year":"2010","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2024.08.034_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/OPTO.S350185","article-title":"Artificial tears: a systematic review","volume":"15","author":"Semp","year":"2023","journal-title":"Clin Optometry"},{"key":"10.1016\/j.ajo.2024.08.034_bib0006","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2147\/OPTH.S226168","article-title":"Real-world treatment patterns of cyclosporine ophthalmic emulsion and lifitegrast ophthalmic solution among patients with dry eye","volume":"13","author":"White","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2024.08.034_bib0007","article-title":"Autologous serum eye drops for dry eye","volume":"2017","author":"Pan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajo.2024.08.034_bib0008","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/5584_2018_219","article-title":"Therapeutic potential of mesenchymal stem cell-derived exosomes in the treatment of eye diseases","volume":"1089","author":"Harrell","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ajo.2024.08.034_bib0009","doi-asserted-by":"crossref","first-page":"44364","DOI":"10.1038\/srep44364","article-title":"Effects of silk fibroin in murine dry eye","volume":"7","author":"Kim","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.ajo.2024.08.034_bib0010","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1038\/nprot.2011.379","article-title":"Materials fabrication from Bombyx mori silk fibroin","volume":"6","author":"Rockwood","year":"2011","journal-title":"Nature Protocols"},{"issue":"4","key":"10.1016\/j.ajo.2024.08.034_bib0011","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1021\/acsbiomaterials.5b00556","article-title":"Optimizing molecular weight of lyophilized silk as a shelf-stable source material","volume":"2","author":"Kluge","year":"2016","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.ajo.2024.08.034_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1285823","article-title":"Application of food-grade proteolytic enzyme for the hydrolysis of regenerated silk fibroin from Bombyx mori","volume":"2018","author":"Joung","year":"2018","journal-title":"J Chem"},{"issue":"11","key":"10.1016\/j.ajo.2024.08.034_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188154","article-title":"Treatment with solubilized Silk-Derived Protein (SDP) enhances rabbit corneal epithelial wound healing","volume":"12","author":"Abdel-Naby","year":"2017","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.ajo.2024.08.034_bib0014","article-title":"Effect of silk fibroin protein hydrolysis on biochemistry, gelation kinetics, and NF-\u03baB bioactivity in vitro","volume":"272","author":"Lawrence","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"10.1016\/j.ajo.2024.08.034_bib0015","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1167\/iovs.16-19957","article-title":"Silk-derived protein enhances corneal epithelial migration, adhesion, and proliferation","volume":"58","author":"Abdel-Naby","year":"2017","journal-title":"Investig Ophthalmol Visual Sci"},{"key":"10.1016\/j.ajo.2024.08.034_bib0016","series-title":"ARVO Annual Meeting Abstracts","first-page":"2820","article-title":"Silk-derived protein-4 (SDP-4) Inhibits Nuclear Factor Kappa B (NF-\u03baB) inflammatory signaling that underlies dry eye disease (DED)","author":"Infanger","year":"2019"},{"issue":"5","key":"10.1016\/j.ajo.2024.08.034_bib0017","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.foodcont.2006.02.002","article-title":"Antimicrobial and antioxidant effects of sodium acetate, sodium lactate, and sodium citrate in refrigerated sliced salmon","volume":"18","author":"Sallam","year":"2007","journal-title":"Food Control"},{"issue":"7","key":"10.1016\/j.ajo.2024.08.034_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0276-5","article-title":"Acetate attenuates inflammasome activation through GPR43-mediated Ca2+-dependent NLRP3 ubiquitination","volume":"51","author":"Xu","year":"2019","journal-title":"Exp Mol Med"},{"issue":"2","key":"10.1016\/j.ajo.2024.08.034_bib0019","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/jop.2008.0098","article-title":"Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells","volume":"25","author":"Epstein","year":"2009","journal-title":"J Ocular Pharmacol Therap"},{"issue":"6","key":"10.1016\/j.ajo.2024.08.034_bib0020","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2125.2004.02103.x","article-title":"The revision of the Declaration of Helsinki: past, present and future","volume":"57","author":"Carlson","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.ajo.2024.08.034_bib0021","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ophtha.2015.02.037","article-title":"Comparison of two questionnaires for dry eye symptom assessment the ocular surface disease index and the symptom assessment in dry eye","volume":"122","author":"Amparo","year":"2015","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2024.08.034_bib0022","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1542-0124(12)70053-8","article-title":"Development and validation of a short global dry eye symptom index","volume":"5","author":"Schaumberg","year":"2007","journal-title":"The ocular surface"},{"issue":"3","key":"10.1016\/j.ajo.2024.08.034_bib0023","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00003226-200404000-00010","article-title":"The repeatability of clinical measurements of dry eye","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2024.08.034_bib0024","first-page":"221","article-title":"Report of the national eye institute\/industry workshop on clinical trials in dry eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"Off J Contact Lens Assoc, Inc"},{"issue":"12","key":"10.1016\/j.ajo.2024.08.034_bib0025","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.ophtha.2015.08.001","article-title":"Lifitegrast ophthalmic solution 5.0% versus placebo for treatment of dry eye disease: results of the randomized phase III OPUS-2 study","volume":"122","author":"Tauber","year":"2015","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2024.08.034_bib0026","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/tjo.TJO-D-22-00140","article-title":"Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen","volume":"13","author":"Chan","year":"2023","journal-title":"Taiwan J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.08.034_bib0027","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/bjophthalmol-2019-315747","article-title":"Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review","volume":"105","author":"Aragona","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2024.08.034_bib0028","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3390\/ijms23052434","article-title":"Artificial tears: biological role of their ingredients in the management of dry eye disease","volume":"23","author":"Labetoulle","year":"2022","journal-title":"Int J Mol Sci"}],"updated-by":[{"DOI":"10.1016\/j.ajo.2025.08.026","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000}}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424003969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424003969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T22:21:23Z","timestamp":1738621283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939424003969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":28,"alternative-id":["S0002939424003969"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2024.08.034","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silk-Derived Protein-4 Versus Vehicle Control in Treating Patients With Moderate to Severe Dry Eye Disease: A Randomized Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2024.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}